Based on the proven importance of the CCL2/CCR2 axis in mouse and human OCP migration, we propose the addition of CCL2/CCR2 blockade early at the course of arthritis as a promising approach to reduce osteoresorptive damage. This evidence concerns the gene CCL2 and arthritic joint disease.